Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and Index

Forside
Division of the Federal Register, the National Archives, 1963
Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries.
 

Andre utgaver - Vis alle

Vanlige uttrykk og setninger

Populære avsnitt

Side 410 - ... be read in evidence or whether additional copies shall be required to be submitted within a time to be specified by the presiding officer.
Side 42 - oleomargarine" or "margarine" includes- — (1) all substances, mixtures, and compounds known as oleomargarine or margarine ; {2) all substances, mixtures, and compounds which have a consistence similar to that of butter and which contain any edible oils or fats other than milk fat if made in imitation or semblance of butter.
Side 49 - That no additive shall be deemed to be safe if it is found to induce cancer when ingested by man or animal, or if it is found, after tests which are appropriate for the evaluation of the safety of food additives, to induce cancer in man or animal...
Side 408 - Secretary pursuant to subsection (b), do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested...
Side 9 - ... label space for the prominent placing of such word, statement, or information; (4) Insufficiency of label space for the prominent placing of such word, statement, or information, resulting from the use of label space for any word, statement, design, or device which is not required by or under authority of the act to appear on the label: (5) Insufficiency of label space for the prominent placing of such word, statement, or information, resulting from the...
Side 20 - Labeling on or within the package from which the drug is to be dispensed bears adequate information for its use, including indications, effects, dosages, routes, methods, and frequency and duration of administration, and any relevant hazards, contraindications, side effects, and precautions...
Side 413 - If the article is offered for use in arthritis or rheumatism, the labeling prominently bears a statement that the beneficial effects claimed are limited to the temporary relief of minor aches and pains of arthritis and rheumatism and, in juxtaposition with directions for use in such conditions, a conspicuous warning statement, such as “Caution: If pain persists for more than 10 days, or redness is present, or in conditions affecting children under 12 years of age, consult a physician immediately”.
Side 210 - Excessively Mealy." Such alternative statement shall immediately and conspicuously precede or follow. without intervening written, printed, or graphic matter, the name "Peas" and any words and statements required or authorized to appear with such name by [20 FR 9616.
Side 15 - ... of the act by reason (among other reasons) of: (1) The failure of such word, statement, or information to appear on the part or panel of the label which is presented or displayed under customary conditions of purchase; (2) The failure of such word, statement, or information to appear on two...
Side 27 - English. (2) If the label contains any representation in a foreign language, all words, statements, and other information required by or under authority of the act to appear on the label shall appear thereon in the foreign language.

Bibliografisk informasjon